In the Berlin Institute of Health (BIH), the Max Delbrück Center for Molecular Medicine (MDC) and the Charité - Universitätsmedizin Berlin have joined forces. Our core idea is to combine translational research with an overarching systems medicine approach to bridge the gap between basic research and clinical application. We are bringing these two worlds of science together in a shared research space, since close exchange between experimental research and medical practice is crucial when it comes to developing improved diagnostic, therapeutic, and preventive procedures for the sake of human health.

Founded in the beginning of 2013 as a cooperation of MDC and Charité, the BIH is scheduled for 2015 to become a corporation under public law (Körperschaft öffentlichen Rechts). This will lift the long-standing project-based collaboration of MDC and Charité to an institutional level and create a novel structure for translational research. Both partners, MDC and Charité, will keep their status as legal entities. First research projects and fundings have started March 2014.

For further information about the BIH, research projects, contact details, open calls, open positions and education activities, please go to


BIH-NEWS: If you would like to be kept informed about the latest developments and funding opportunities at the BIH, you can subscribe to our mailing list. You can unsubscribe from the list at any time.